Penn Medicine Provider
Infectious Diseases
Judith A. O'Donnell, MD
Accepting new patients
Sees patients age 18 and up
Penn Infectious Diseases Penn Presbyterian

About me

  • Associate Chief Medical Officer for Healthcare Epidemiology, University of Pennsylvania Health System
  • Director and Senior Epidemiologist, Department of Infection Prevention & Control Penn Presbyterian Medical Centerl
  • Section Chief, Division of Infectious Diseases Penn Presbyterian Medical Center
  • Professor of Clinical Medicine (Infectious Diseases)

Education and training

  • Medical School: Temple University School of Medicine
  • Residency: Temple University Hospital
  • Fellowship: Temple University Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. O'Donnell is a Penn Medicine physician.

Qualifications and experience

My research

Kevin He and Judith A. O'Donnell Chlamydial Proctitis , New England Journal of Medicine, 391: 2024,1237


Weinstein EJ, Stephens-Shields A, Newcomb CW, Silibovsky R, Nelson CL, O’Donnell JA, Glaser LJ, Hsieh E, Hanberg JS, Tate JP, Akgun KM, King JT, LoRe V. Incidence microbiology, and determinants of prosthetic joint infections according to time following total knee arthroplasty: a retrospective cohort study among US veterans. , JAMA Network Open, 6: 2023


Anesi GL, Degnan K, Dutcher L, Saw S, Maguire C, Binkley A, Patel S, Athans V, Barton TD, Binkley S, Candeloro C, Herman DJ, Kasbekar N, Kennedy L, Millstein JH, Meyer NJ, Talati NJ, Patel H, Pegues DA, Sayre PJ, Tebas P, Terico AT, Murphy KM, O’Donnell JA, White M, and Hamilton KW. The Penn Medicine COVID-19 therapeutics committee – reflections on a model for rapid evidence review and dynamic practice recommendations during a public health emergency. , Open Forum Infect Dis.: 2023


Richterman A, Behrman A, Brennan PJ, O’Donnell JA, Snider CK, Chaiyachati KH. Durability of SARS-CoV-2 messenger RNA booster vaccine protection against omicron among health care workers with a vaccine mandate. , Clin Infect Dis.: 2022


Green-McKenzie J, Shofer FS, Momplaisir F, Kuter BJ, Kruse G, Bialal U, Behta, M, O’Donnell JA, Al-Ramahi N, Kasbekar, Sullivan P, Okala P, Brennan PJ. Factors associated with COVID-19 vaccine receipt by healthcare personnel at a major academic hospital during the first months of vaccine availability. , JAMA Network Open., 4: 2021


Mahraj K, Chaiyachati KH, Asch DA, Fala G, Do D, Lam D, Miller A, Mannion N, Stoloff V, Halbritter A, Huffenberger AM, Shuttleworth J, O’Donnell JA, Green-McKenzie J, Patel K, Rosin R, Kruse G, Brennan PJ, Volpp KG. How a University and Health System Jointly and Rapidly Developed a Large-Scale COVID-19 Surveillance System with Limited Time and Capacity Constraints , NEJM Catalyst Innovations in Care Delivery, 2(6): 2021


Weinstein E, Stephens-Shields A, Loabile B, Yuh, T, Silibovsky R, Nelson CL, O’Donnell JA, Hsieh E, Hanberg JS, Akgun KM, Tate JP, LoRe V. Development and validation of case-findings algorithm to identify prosthetic joint infection after total knee arthroplasty in Veterans health administration data. , Pharmacoepidemiology and Drug Safety: 2021


Liu P, Hamilton KW, O’Donnell JA Urinary Tract Infections , Schlossberg's Clinical Infectious Disease : 2021,422-429


O’Donnell, JA, Gelone SP, Talati, NJ Topical Antibacterials , Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, Ninth Edition. Bennett JE, Dolin R, Blaser, MJ eds.: 2020,466-72


Gelone SP, Pacetti S, O'Donnell JA Principles of Antimicrobial Therapy , Pharmacotherapeutics for Advanced Practice: A Practical Approach, Fourth Edition: 2017,111-134